Skip to content
OpenCapital
Get started

Rapid Micro Biosystems RPID Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
——

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's available for sale securities debt securities current?
Rapid Micro Biosystems (RPID) reported available for sale securities debt securities current of $9.13M in Q1 2026.
How has Rapid Micro Biosystems's available for sale securities debt securities current changed year-over-year?
Rapid Micro Biosystems's available for sale securities debt securities current decreased by 59.9% year-over-year, from $22.76M to $9.13M.
What is the long-term trend for Rapid Micro Biosystems's available for sale securities debt securities current?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's available for sale securities debt securities current has grown at a 4.9% compound annual growth rate (CAGR), from $15.11M to $18.27M.